Santa Monica, CA – Faster Cures, a research center at the Milken Institute, summarized their recent webinar on April 7th and offers an in-depth explanation on the U.S. Food and Drug Administration's (FDA) Patient-Focused Drug Development (PFDD) initiative. The webinar speakers highlight that “under the fifth authorization of the Prescription Drug User Fee Act (PDUFA) to hold at least 20 disease-specific meetings to better understand patients' experiences with symptoms, impacts on daily living, and available therapies.”
0 Comments
New Brunswick, NJ - Michigan has autos. The Midwest has agribusiness. Texas has oil and gas. California’s Silicon Valley has electronics. And New Jersey has the life sciences industry. When Johnson & Johnson opened its doors in 1886 in a former New Brunswick wallpaper factory, it was the launch of what is today one of the largest healthcare companies in the world. It also was the genesis of what is currently the greatest concentration of life sciences companies not only in the United States but in the world — and New Jersey’s premier industry.
Summit, NJ - These are exciting times for Celgene and promising times for the patients we serve. We continue to deliver on multiple opportunities, translating the potential of transformational science into disease-altering and life-enhancing innovative medicines with the goal of helping patients with critical unmet medical needs worldwide live longer and better lives. This dedication to patients is aligned with our corporate vision, mission and values and reflects our unwavering commitment to put patients first. By advancing the course of healthcare through bold scientific pursuits and medical innovation we are making it possible for societies to progress and economies to prosper.
Boonton Township, NJ - According to the New Jersey Business Magazine, "Enteris BioPharma, Inc., which focuses on oral peptide delivery, announces the launch of contract manufacturing located within its 32,000-square-foot, FDA inspected and cGMP compliant facility in Boonton. Equipped to ensure cost-effective, high-quality production of API using microbial expression systems, Enteris BioPharma offers pharmaceutical companies a full array of services to meet their manufacturing needs, from pre-clinical to commercial scale."
|
Do not miss a single innovative moment and sign up for our newsletter!
|